Steven P. Coen - 28 Jul 2023 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Accounting Officer
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Issuer symbol
DNA
Transactions as of
28 Jul 2023
Net transactions value
$0
Form type
4
Filing time
28 Jul 2023, 17:08:54 UTC
Previous filing
19 May 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Award $0 +1,127,820 $0.000000 1,127,820 28 Jul 2023 Class A Common Stock 1,127,820 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 The RSUs vest as follows: 25% of the underlying shares on May 1, 2024, then 36 equal monthly installments thereafter.

Remarks:

Chief Accounting Officer